Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-23-035690

Director sold 1,485 shares at $51.65 ($76,700)

  • Director acquired 3,860 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Sanders Corazon (Corsee) D. Director 2023-06-07 Grant or award +3,860 11,055 D: show line 1 in the form
Sanders Corazon (Corsee) D. Director 2023-06-08 Sale −1,485 $51.65 $76,700 9,570 D: show line 2 in the form
Open-market sales · 1,485 sh · avg $51.65 · $76,700

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Sanders Corazon (Corsee) D. Director 2023-06-07 Grant or award · Stock Option (Right to Buy) +7,110 7,110 D: show line 3 in the form
Loading xslF345X04/doc4.xml…